Eli Lilly and Co LLY

Morningstar Rating
$887.16 +1.61 (0.18%)
View Full Chart

Company Report

Price vs Fair Value

LLY is trading within a range we consider fairly valued.
Price
$887.16
Fair Value
$918.00
Uncertainty
High
1-Star Price
$667.00
5-Star Price
$465.00
Economic Moat
Kdqd
Capital Allocation
Bbfmvdgdh

Bulls Say, Bears Say

Bulls

Lilly's strong leadership in weight-loss drugs should drive industry-leading growth with approved drugs and well-positioned next-generation weight-loss drugs in the pipeline.

Bears

The risks to success for Alzheimer’s drug Kisunla remain high because of bottlenecks in patient diagnosis, required scans and monitoring, as well as competition.

News

Trading Information

Previous Close Price
$885.55
Day Range
$876.89888.97
52-Week Range
$531.61972.53
Bid/Ask
$884.25 / $886.24
Market Cap
$798.82 Bil
Volume/Avg
2.0 Mil / 3.2 Mil

Key Statistics

Price/Earnings (Normalized)
79.49
Price/Sales
20.60
Dividend Yield (Trailing)
0.57%
Dividend Yield (Forward)
0.59%
Total Yield
0.57%

Company Profile

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Growth
Total Number of Employees
43,000

Competitors

Valuation

Metric
LLY
MRK
BMY
Price/Earnings (Normalized)
79.4916.867.04
Price/Book Value
58.906.396.43
Price/Sales
20.604.482.36
Price/Cash Flow
79.8714.927.24
Price/Earnings
LLY
MRK
BMY

Financial Strength

Metric
LLY
MRK
BMY
Quick Ratio
0.610.880.94
Current Ratio
1.111.471.16
Interest Coverage
15.0813.07−3.16
Quick Ratio
LLY
MRK
BMY

Profitability

Metric
LLY
MRK
BMY
Return on Assets (Normalized)
13.15%15.46%3.04%
Return on Equity (Normalized)
69.16%41.15%11.63%
Return on Invested Capital (Normalized)
23.97%22.92%5.77%
Return on Assets
LLY
MRK
BMY

Drug Manufacturers - General Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Johnson & Johnson
JNJ
HpqhpjqHyyp$385.9 Bil
AbbVie Inc
ABBV
SkcqqtcQbd$343.2 Bil
Merck & Co Inc
MRK
NthvqxtnHhgcz$278.2 Bil
Roche Holding AG ADR
RHHBY
GldsrgtkjDvdh$244.4 Bil
AstraZeneca PLC ADR
AZN
CcbpdrfzgTnvqq$238.9 Bil
Novartis AG ADR
NVS
HpzsxhycZtzw$232.2 Bil
Amgen Inc
AMGN
CgzcfrbbfFqfl$171.8 Bil
Pfizer Inc
PFE
HxsqxwgSljkl$162.0 Bil
Sanofi SA ADR
SNY
JwdccjkvLrz$140.7 Bil

Sponsor Center